Another study of 10-year recurrence in European breast cancer patients announced that those with HR−/HER2+ and TNBC had a significantly higher recurrence and metastasis rate than HR-positive profiles, which was in agreement with our findings [22]. The gene discussed is ERBB2; the disease is breast carcinoma.